MetaCap

Anbio Biotechnology Statistics

NASDAQ: NNNNHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD

3.32-0.33 (-9.04%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Anbio Biotechnology by the numbers

Anbio Biotechnology has a market capitalization of $145.7 million based on 43.89M shares outstanding. Its trailing P/E ratio is 22.1. The stock trades 25.6% below its 50-day average and 78.7% below its 200-day average.

Average daily trading volume is 128.35K shares, or about $426,135 in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

NNNN valuation vs. peer median

NNNN compared with the median of 8 peer companies
MetricNNNNPeer medianDifference
Market cap$145.72M$5.02M+2803%
Avg. volume128.35K167.42K-23%

Peer median across 8 companies: ICCC, IMDX, VNRX, TRIB, BMRA, CDIO, QCLS, VRAX.

Valuation

Market cap
$145.72M
Price / sales (latest FY)
16.85

Price and trading

Previous close
3.65
Open
3.65
Day range
3.31 – 3.93
52-week range
3.09 – 44.73
52-week change
-86.02%
Beta
—
Volume
79.51K

Dividends and events

Annual dividend
None
Next earnings date
Apr 28, 2025

Additional statistics

Market Cap
145.72M
Pe
22.13
Eps
0.15
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
44.73
Week52 Low
3.09
Avg Volume
128.35K
Shares Outstanding
43.89M
Ma50
4.47
Ma200
15.61
Earnings Date
Apr 28, 2025
Pct From52w High
-92.58%
Pct From52w Low
7.44%

Related